Agilent Technologies Inc.'s non-GAAP EPS for the third quarter of fiscal year 2019 was 76 cents, compared with the S&P Global Market Intelligence consensus normalized EPS estimate of 72 cents.
The Santa Clara, Calif.-based manufacturer of lab equipment and software said its EPS rose 13.4% year over year from 67 cents.
Non-GAAP income totaled $240 million, a gain of 10.6% from $217 million in the prior-year period.
Agilent's GAAP net income declined 19.1% from the prior-year period to $191 million, or 60 cents per share, from $236 million, or 73 cents per share.
The company's revenue climbed 5.8% on an annual basis to $1.27 billion in the third fiscal quarter from $1.20 billion.
For the fourth fiscal quarter, the company expects its non-GAAP EPS to be between 84 cents and 86 cents, with revenue estimated to be in the range of $1.31 billion to $1.33 billion. The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter is 87 cents.
The company's yearly and quarterly guidance excludes any impact of its pending $1.17 billion acquisition of BioTek Instruments Inc., which is targeted for completion in the fiscal fourth quarter.
Agilent raised its non-GAAP EPS forecast to range between $3.07 and $3.09 for fiscal 2019 from its previous expectation of non-GAAP EPS between $3.03 and $3.07. The company expects its full-year revenue to be at the midpoint between $5.11 billion and $5.13 billion, compared to the previous target of about $5.09 billion.
For the fiscal year, the S&P Global Market Intelligence consensus normalized EPS estimate is $3.05.